Objectives. Compared to type 1 diabetes, the role of the immune and autoimmune pathogenetic mechanisms is much less studied in the type 2 diabetes. Toll-like receptors 4 (TLR4) have a leading role in infl ammation, insulin resistance, and vascular damage. Th is study aimed to analyze the relationship between the polymorphisms in TLR4 gene and diff erent stages in the glucose continuum from prediabetes to the type 2 diabetes and chronic microvascular complications.
Having in mind the insidious development of the type 2 diabetes (T2D), the diff erence in the evolution of any of its complication and the principle "the earlier, the better the treatment", it is important to identify the predisposing factors for their progress.
Compared to the type 1 diabetes (T1D), the role of immune and autoimmune pathogenetic mechanisms is much less studied in T2D. During the last decades the scientifi c interest has been broadened to the earlier stages in the glucose continuum and development of the disease -risk factors and prediabetes. Nonspecifi c immune system participates actively in the pathogenesis of obesity and metabolic syndrome (Festa et al. 2000) . T2D is considered to be a state, characterized by chronic low-grade infl ammation (Spranger et al. 2003) . One of the pathways for initiation of innate immune response is through toll-like receptors (TLRs). Th ey are pattern recognition receptors (PRRs), which recognize antigens with repeated pathogen-associated molecular patterns (PAMPs). Th eir activation induces a cascade signaling with a fi nal eff ect -transcription of genes of infl ammatory cytokines through the NFκB pathway (Kawasaki and Kawai 2014) . Cytokines are involved in phosphorylation of insulin receptor substrates and further changes in post-receptor signaling. Th us TLR2 and TLR4 have been implicated to participate in progress of insulin resistance (Shi et al. 2006) . Hyperglycemia is associated with their stimulation and studies have demonstrated they are overexpressed in patients with diabetes -both the type 1 ) and the type 2 (Dasu et al. 2010) .
T2D is a polygenic disease and the presence of a variety of polymorphisms seems to be altering the risk of the disease when external factors interfere. As the immune system actively participates in its pathogenesis, polymorphisms in the genes encoding innate immune response factors have been researched for a predisposing role -C-reactive protein (CRP) (Wolford et al. 2003) , tumor necrosis factor alpha (TNFα) (Fernandez-Real et al. 1997) , interleukin 6 (IL-6) (Illig et al. 2004) , plasminogen activator inhibitor-1 (PAI-1) (Hoff stedt et al. 2002) , transforming growth factor beta (TGFβ) (Rosmond et al. 2003) , etc.
TLR4 gene, encoding TLR4, has also been evaluated as a risk factor for T2D (Bagarolli et al. 2010) . Products of its transcription actively participate in the innate immune response in the metabolic syndrome and induction of insulin resistance (Weyrich et al. 2010) . As hyperglycemia also contributes to immune system activation through oxidative stress products, advanced glycation end products (AGEs), etc. (Forbes and Cooper 2013) , polymorphisms in TLR4 gene are also potential predictors for the risk of chronic complications of diabetes.
Research on TLR4 gene has described a number of nonsynonymous polymorphisms. A population frequency exceeding 5% has been shown for two -one with a nucleotide sequence, leading to the exchange of the amino acid Aspartate with Glycine on 299th place of the encoded peptide (rs4986790), defi ned by A and G alleles respectively, and the other leading to replacement of Th reonine with Isoleucine on 399th place (rs4986791) of the peptide structure (Ferwerda et al. 2008) , defi ned by C and T allele, respectively.
According to the NCBI HapMap database, the allele frequency of rs4986790 in European studies varies between 0.9499 and 0.9666 for allele A, and between 0.0500 and 0.0333 for allele G. Concerning rs4986791, the allele frequency for the wild allele C varies between 0.9499 and 0.9553, and between 0.5000 and 0.0446 for T allele, respectively.
Both genetic variants have been related to altered responsiveness to ligands (Arbour et al. 2000) and thus have become the subject of many studies exploring genetic background of diseases (Noreen et al. 2012) .
Th e aim of this study was to characterize the association between Asp299Gly and Th r399Ile polymorphisms of TLR4 gene and presence of T2D and prediabetes in a sample of Bulgarian population and to describe their relation to chronic diabetic complications.
Subjects and Methods
Th e protocol of the study was in accordance with the declaration of Helsinki and was approved by the ethics committee of Medical University-Sofi a. All participating subjects signed a written informed consent. Th e study included 113 patients with T2D and 29 subjects with prediabetes (14 with impaired fasting glucose and 15 with impaired glucose tolerance), all diagnosed according to criteria of the American Diabetes Association (ADA, 2010) . Th e control group consisted of 28 clinically healthy volunteers. Exclusion criteria were duration of diabetes more than 10 years, T1D, malignant and acute or chronic infl ammatory diseases, estimated glomerular fi ltration rate (eGFR) < 60 ml/min/m 2 , pregnancy. Fasting plasma glucose (FPG) and postprandial plasma glucose (PPG) -two hours post lunch meal, HbA1c of the enrolled subjects were assessed by standard laboratory techniques in the Central Laboratory of the Alexandrovska University Hospital, which is the referent one for Bulgaria. Diabetic polyneuropathy was assessed semiquantitatively through Neuropathy Disability Score (Weintrob et al. 2007; Yang et al. 2014) . Fundoscopy for diabetic retinopathy was performed by an ophthalmologist. EGFR was calculated through Th e Modifi cation of Diet in Renal Disease (MDRD) formula: 186 × (Creatinine, μmol/l / 88.4) -1.154 × (Age) -0.203 (× (0.742 for women). Genotyping. High molecular weight DNA was extracted from nuclear blood cells for genetic analysis. Blood was obtained in a plastic tube with K3 EDTA (Ethylenediaminetetraacetic acid) as an anticoagulant. Blood was kept at +4 °C for maximum 48 hours. Th e salting out protocol of Miller et al. (1998) was used for the extraction of genomic DNA.
Th e polymorphic region of the TLR4 gene was amplifi ed by polymerase chain reaction (PCR) with the following primer sets as described by Nyati et al. (2010) :
Reverse 5' GATCAACTTCTGAAAAAGCATTC-CCAC 3'; TLR4 Th r399Ile -Forward 5' GGTTGCTGTTCT-CAAAGTGATTTTGGGAGAA 3'
Reverse 5' ACCTGAAGACTGGAGAGTGAGA-GTTAAATGCT 3'.
Th e PCR was performed in a reaction volume of 15 μl containing 10× PCR buff er, 200 μM each of the dNTPs, 2 mM of MgCl 2 , 15 pmol of each primer, 1.25 U of Taq DNA polymerase and 100 ng of genomic DNA as a template. PCR amplifi cations were performed in a thermocycler with an initial denaturation at 94 °C for 5 min. Th e thermal cycle was repeated 30 times: denaturation at 95 °C for 30 s, annealing for 60 s at 53 °C for Asp299Gly and at 60 °C for Th r399Ile, and extension at 72 °C for 60 s. A fi nal extension of fi ve minutes at 72 °C followed. PCR product was 249 bp (base pairs) for Asp299Gly and 407 bp for Th r399Ile.
TLR4 Asp299Gly polymorphisms were detected through Nco I restriction endonuclease. Restriction was performed overnight at 37 °C, fragments were separated through 3.0% agarose gel electrophoresis.
TLR4 Th r399Ile polymorphisms were detected through Hinf I restriction endonuclease. Restriction was performed overnight at 37 °C, fragments were separated through 2.5% agarose gel electrophoresis. Recognized sequences and restriction fragments are presented on Table 1 .
Statistical analysis. Statistical analysis was performed with SPSS 19 Statistics Package (Chicago, Illinois). Chi square test or Fisher exact test were used for assessing diff erences in frequencies between groups. Оdds ratio (OR) with confi dence interval (CI) of 95% have also been calculated. Student's t-test or nonparametric Mann Whitney U test were used for assessing data between independent samples. P values less than 0.05 were considered signifi cant.
Results
Clinical and laboratory characteristics of the participants are presented in Table 2 . Gender distribution between diabetes (57.5%, n=65) and control groups (46.2%, n=13) did not diff er signifi cantly (p=0.291), but the percentage of women (86.2%, n=25) enrolled with prediabetes exceeded that in the other two groups (p<0.005).
Genotypes did not diff er signifi cantly from expected by Hardy-Weinberg equilibrium in neither group (T2D: p=0.696 for Asp299Gly and p=0.581 for Th r299Ile; prediabetes: p= 0.768 and p=0.064; control group: p=0.845 and p=0.838, respectively for both polymorphisms).
A signifi cant diff erence in the allele and genotype frequency of Asp299Gly and Th r399Ile polymorphism in TLR4 gene in patients with T2D and prediabetes compared to controls was not found (Table 3 ). All participants who had the G allele for Asp299Gly were also heterozygous for Th r399Ile polymorphism. Th ree patients with T2D were heterozygous for Th r399Ile only. We did not fi nd a homozygous genotype for the recessive alleles of both analyzed polymorphisms within the T2D group. Only one patient with prediabetes was homozygous for the recessive allele of Th r399Ile polymorphism.
T2D Taking into consideration the lack of signifi cance in diff erence between the latter factors, we observed an association between Asp299Gly polymorphism and diabetic retinopathy, diagnosed through fundoscopy. Prevalence of diabetic retinopathy was higher among participants with T2D who also had the heterozygous genotype rather than the homozygous one (p=0.033). For Th r399Ile polymorphism such diff erence was not of signifi cance. Both polymorphisms were not associated with prevalence of diabetic polyneuropathy (Table 4) .
Th e mean level of eGFR was the highest in the T2D group, signifi cantly diff ering from that of the control subjects (Table 2) . Th is was probably related to hyperfi ltration in participants with T2D. Within the latter group, the eGFR was not signifi cantly changed depending on presence of both genotypes of both analyzed polymorphisms. Results are detailed in Table 4 .
Discussion
Asp299Gly and Th r399Ile polymorphisms have been associated with a protective role for development of T2D (Kolek et al. 2004 ) but a predisposing one for metabolic syndrome (Steinhardt et al. 2010; Cuda et al. 2011) . Th e combination of both recessive alleles has even been observed to provide the greatest protection against T2D (Manolakis et al. 2011) . However, not all studies confi rm such results (Illig et al. 2003; Maldonado-Bernal et al. 2011) . A recent metaanalysis showed that neither polymorphism is related to the prevalence of T2D (Yin et al. 2015) .
Th e current results showed a lack of association of the genotyped polymorphisms with both T2D and the prediabetic state in the analyzed sample of a Bulgarian population. Th e genotype frequency was similar between both cohorts and the analyzed polymorphisms did not seem to alter the risk for the progress of a prediabetic state to T2D, as has been suggested for other genetic variants (Andrulionyte et al. 2006) . However, these results could be infl uenced by the low number of patients included and larger cohort would exclude an association between the polymorphisms and the glucose continuum.
Th e heterozygous genotypes of both Asp299Gly and Th r399Ile polymorphisms have been found to lower the risk of diabetic neuropathy (Rudofsky et al. 2004 ). However, Buraczynska et al. (2009) described a predisposing role of the G allele of Asp299Gly to both developments of retinopathy and cardio-vascular disease, but did not confi rm an association with other microvascular complications (Buraczynska et al. 2016 ).
In the current study, it was confi rmed that T2D participants with a heterozygous genotype of Asp299Gly had a higher prevalence of diabetic retinopathy, despite that the patients' number was low, as has been shown previously (Buraczynska et al. 2009 ). However, the polymorphism was not related to the development of polyneuropathy and did not aff ect the renal function, assessed through eGFR. Th e current fi ndings were independent of patients' age, duration of the disease, glucose and weight control and arterial blood pressure that could impact progress of chronic complications. It is mainly Asp299Gly not Th r399Ile polymorphism that leads to modifi ed peptide structure, alters ligand-receptor interaction, post-receptor signaling and further cytokine production (Ferwerda et al. 2008; Ohto et al. 2012; Long et al. 2014) . TLR4 actively contributes to the infl ammatory response in development of microvascular complications, including diabetic retinopathy (Rajamani and Jialal 2014) . Th e NFκB pathway is stimulated by hyperglycemia, reactive oxygen species, AGEs -all implicated in the pathogenesis of diabetes-associated vascular damage (Forbes and Cooper 2013) . It is expected that conformational variants in TLR4, resulting from nucleotide replacement, impact receptor activation and defi ne the subsequent infl ammatory response to structural changes in vessel wall. Moreover, the TLR4 signaling pathway, being activated by high-mobility group box-1 (HMGB1) -an endogenous TLR ligand, released by necrotic cells, is responsible for the production of a proangiogenic factor for ischemia-induced retinal neovascularization (He et al. 2013 ). However, whether TLR4 polymorphisms are related to angiogenesis remains to be elucidated.
Taken together, TLR4 polymorphisms may not be crucial for the induction of insulin resistance and glycemic disorders, but their contribution to progress of diabetic complications should not be underestimated. Th e risk of chronic complications is individual among patients with T2D. Th e TLR4 gene polymorphisms may be one of the determining factors in their development.
To our knowledge, this is the fi rst study investigating the TLR4 polymorphisms in the glucose continuum. Th e study has some limitations. Th e number of participants was low. Gender distribution in prediabetes group diff ered from that in the other two groups. Diabetic retinopathy was diagnosed by fundoscopy and not fl uorescence angiography, considered the gold standard for evaluating the retinal vasculature (Salz and Witkin 2015) .
Conclusion
According to the current study the Asp299Gly and Th r399Ile polymorphisms of TLR4 gene seemed not to be associated with T2D and prediabetes. However, the heterozygous genotype for Asp299Gly polymorphism appeared to defi ne an increased risk for diabetic retinopathy -a major disabling complication of diabetes.
